REMOWELL2

THE SOLUTION FOR EXTENDED CPB DURATION

Categories: ,

Description

REMOWELL2 is designed to reduce neurological injury and inflammatory response in Patients undergoing cardiac surgery, thanks to its unique and patented cardiotomy features capable to reduce lipids and leukocytes cells coming from pericardial suction blood. Literature evidenced the efficacious filtration by REMOWELL technology of LME (Lipid Micro Emboli) in the clinical setting and the subsequent attenuation of NSE release, a known marker of neurologic injury. In addition, significantly lower concentration of cystatin C, a known biomarker of kidney function, was found in the postoperative period, suggesting a renoprotective role for LME filtration9. The Remowell filtration technology, effectively contribute to reduce inflammatory response and minimize the negative effects of cardiopulmonary bypass.

Esrosets Remowell2 Brochure

PDF File

Oxygenating device for extracorporeal circulation in cardio surgery

PDF File

Clinical evaluation of a novel filtering device fo9r 'shed blood' during culminary bypass

PDF File

Lipid Micro Emboli and Leukocyte Filtration: A Critical Review

PDF File

Evaluation of the effectiveness of a lipid and leukocyte removing filter during cardiopulminary bypass, and its influence on clinical outcome: preliminary results of a prospective randomized study

PDF File

Fat contamination of pericardial suction and leukocyte filtration in extracorporeal circulation

PDF File

Leukocyte filtration of the cardiotomy suction. Does it affect systemic leukocyte activation or pulmonary function?

Quantification of Lipid Filtration and the Effects on Cerebral Injury During Cardiopulmonary Bypass

Richard W. Issitt, FCCP, Ian Harvey, LCCP, Bronagh Walsh, PhD, and David Voegeli, PhD

Do lipid microemboli induce acute kidney injury during cardiopulmonary bypass?

Richard Issitt,1,2 Tim James,3 Bronagh Walsh2 and David Voegeli2

Efficacy of the RemoweLL cardiotomy reservoir for fat and leucocyte removal from shed mediastinal blood: a randomized controlled trial

PDF File

EVALUATION OF CEREBRAL MICROEMBOLIZATION, LEUCOCYTES AND LIPIDS REMOVAL USING THE NEW OXYGENATOR DEVICE “REMOWELL”.

PDF file

Efficacy of a New Oxygenator-Integrated Fat and Leukocyte Removal Device

PDF File

The use of RemoweLL oxygenatorintegrated device in the prevention of the complications related to aortic valve surgery in the elderly patient: Preliminary results

PDF File